Medical Devices & Consumables
On-body Injectors- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
- Jul 14, 25
- ID: 374855
- Pages: 130
- Figures: 129
- Views: 7
The global market for On-body Injectors was estimated to be worth US$ 176 million in 2024 and is forecast to a readjusted size of US$ 462 million by 2031 with a CAGR of 15.0% during the forecast period 2025-2031.
On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.
The scope of this report is non-insulin On-body injectors.
In the global market, On-body Injectors is dominated by core players such as AWest Pharmaceutical Services, Insulet, Gerresheimer, ect. The top three players within this industry account for about 80% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, and they all hold about 15% of the global market share. The product can be categorised on the basis of product type into electronic syringes and mechanical syringes. The product is widely used in the treatment of oncology immunology, cardiovascular diseases, neurological disorders, and other diseases.
This report aims to provide a comprehensive presentation of the global market for On-body Injectors, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of On-body Injectors by region & country, by Type, and by Application.
The On-body Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding On-body Injectors.
Market Segmentation
By Company
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)
Segment by Type
Electronic Injectors
Mechanical Injectors
Segment by Application
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of On-body Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of On-body Injectors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of On-body Injectors in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.
The scope of this report is non-insulin On-body injectors.
In the global market, On-body Injectors is dominated by core players such as AWest Pharmaceutical Services, Insulet, Gerresheimer, ect. The top three players within this industry account for about 80% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, and they all hold about 15% of the global market share. The product can be categorised on the basis of product type into electronic syringes and mechanical syringes. The product is widely used in the treatment of oncology immunology, cardiovascular diseases, neurological disorders, and other diseases.
This report aims to provide a comprehensive presentation of the global market for On-body Injectors, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of On-body Injectors by region & country, by Type, and by Application.
The On-body Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding On-body Injectors.
Market Segmentation
By Company
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)
Segment by Type
Electronic Injectors
Mechanical Injectors
Segment by Application
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of On-body Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of On-body Injectors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of On-body Injectors in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 On-body Injectors Product Introduction
1.2 Global On-body Injectors Market Size Forecast
1.2.1 Global On-body Injectors Sales Value (2020-2031)
1.2.2 Global On-body Injectors Sales Volume (2020-2031)
1.2.3 Global On-body Injectors Sales Price (2020-2031)
1.3 On-body Injectors Market Trends & Drivers
1.3.1 On-body Injectors Industry Trends
1.3.2 On-body Injectors Market Drivers & Opportunity
1.3.3 On-body Injectors Market Challenges
1.3.4 On-body Injectors Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global On-body Injectors Players Revenue Ranking (2024)
2.2 Global On-body Injectors Revenue by Company (2020-2025)
2.3 Global On-body Injectors Players Sales Volume Ranking (2024)
2.4 Global On-body Injectors Sales Volume by Company Players (2020-2025)
2.5 Global On-body Injectors Average Price by Company (2020-2025)
2.6 Key Manufacturers On-body Injectors Manufacturing Base and Headquarters
2.7 Key Manufacturers On-body Injectors Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of On-body Injectors
2.9 On-body Injectors Market Competitive Analysis
2.9.1 On-body Injectors Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by On-body Injectors Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in On-body Injectors as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Electronic Injectors
3.1.2 Mechanical Injectors
3.2 Global On-body Injectors Sales Value by Type
3.2.1 Global On-body Injectors Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global On-body Injectors Sales Value, by Type (2020-2031)
3.2.3 Global On-body Injectors Sales Value, by Type (%) (2020-2031)
3.3 Global On-body Injectors Sales Volume by Type
3.3.1 Global On-body Injectors Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global On-body Injectors Sales Volume, by Type (2020-2031)
3.3.3 Global On-body Injectors Sales Volume, by Type (%) (2020-2031)
3.4 Global On-body Injectors Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Immuno-oncology
4.1.2 Cardiovascular Diseases
4.1.3 Neurological Diseases
4.1.4 Others
4.2 Global On-body Injectors Sales Value by Application
4.2.1 Global On-body Injectors Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global On-body Injectors Sales Value, by Application (2020-2031)
4.2.3 Global On-body Injectors Sales Value, by Application (%) (2020-2031)
4.3 Global On-body Injectors Sales Volume by Application
4.3.1 Global On-body Injectors Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global On-body Injectors Sales Volume, by Application (2020-2031)
4.3.3 Global On-body Injectors Sales Volume, by Application (%) (2020-2031)
4.4 Global On-body Injectors Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global On-body Injectors Sales Value by Region
5.1.1 Global On-body Injectors Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global On-body Injectors Sales Value by Region (2020-2025)
5.1.3 Global On-body Injectors Sales Value by Region (2026-2031)
5.1.4 Global On-body Injectors Sales Value by Region (%), (2020-2031)
5.2 Global On-body Injectors Sales Volume by Region
5.2.1 Global On-body Injectors Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global On-body Injectors Sales Volume by Region (2020-2025)
5.2.3 Global On-body Injectors Sales Volume by Region (2026-2031)
5.2.4 Global On-body Injectors Sales Volume by Region (%), (2020-2031)
5.3 Global On-body Injectors Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America On-body Injectors Sales Value, 2020-2031
5.4.2 North America On-body Injectors Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe On-body Injectors Sales Value, 2020-2031
5.5.2 Europe On-body Injectors Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific On-body Injectors Sales Value, 2020-2031
5.6.2 Asia Pacific On-body Injectors Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America On-body Injectors Sales Value, 2020-2031
5.7.2 South America On-body Injectors Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa On-body Injectors Sales Value, 2020-2031
5.8.2 Middle East & Africa On-body Injectors Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions On-body Injectors Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions On-body Injectors Sales Value
6.2.1 Key Countries/Regions On-body Injectors Sales Value, 2020-2031
6.2.2 Key Countries/Regions On-body Injectors Sales Volume, 2020-2031
6.3 United States
6.3.1 United States On-body Injectors Sales Value, 2020-2031
6.3.2 United States On-body Injectors Sales Value by Type (%), 2024 VS 2031
6.3.3 United States On-body Injectors Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe On-body Injectors Sales Value, 2020-2031
6.4.2 Europe On-body Injectors Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe On-body Injectors Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China On-body Injectors Sales Value, 2020-2031
6.5.2 China On-body Injectors Sales Value by Type (%), 2024 VS 2031
6.5.3 China On-body Injectors Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan On-body Injectors Sales Value, 2020-2031
6.6.2 Japan On-body Injectors Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan On-body Injectors Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea On-body Injectors Sales Value, 2020-2031
6.7.2 South Korea On-body Injectors Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea On-body Injectors Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia On-body Injectors Sales Value, 2020-2031
6.8.2 Southeast Asia On-body Injectors Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia On-body Injectors Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India On-body Injectors Sales Value, 2020-2031
6.9.2 India On-body Injectors Sales Value by Type (%), 2024 VS 2031
6.9.3 India On-body Injectors Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 West Pharmaceutical Services
7.1.1 West Pharmaceutical Services Company Information
7.1.2 West Pharmaceutical Services Introduction and Business Overview
7.1.3 West Pharmaceutical Services On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 West Pharmaceutical Services On-body Injectors Product Offerings
7.1.5 West Pharmaceutical Services Recent Development
7.2 Insulet
7.2.1 Insulet Company Information
7.2.2 Insulet Introduction and Business Overview
7.2.3 Insulet On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Insulet On-body Injectors Product Offerings
7.2.5 Insulet Recent Development
7.3 Gerresheimer
7.3.1 Gerresheimer Company Information
7.3.2 Gerresheimer Introduction and Business Overview
7.3.3 Gerresheimer On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Gerresheimer On-body Injectors Product Offerings
7.3.5 Gerresheimer Recent Development
7.4 United Therapeutics
7.4.1 United Therapeutics Company Information
7.4.2 United Therapeutics Introduction and Business Overview
7.4.3 United Therapeutics On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 United Therapeutics On-body Injectors Product Offerings
7.4.5 United Therapeutics Recent Development
7.5 CC Bio
7.5.1 CC Bio Company Information
7.5.2 CC Bio Introduction and Business Overview
7.5.3 CC Bio On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 CC Bio On-body Injectors Product Offerings
7.5.5 CC Bio Recent Development
7.6 BD
7.6.1 BD Company Information
7.6.2 BD Introduction and Business Overview
7.6.3 BD On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 BD On-body Injectors Product Offerings
7.6.5 BD Recent Development
7.7 Ypsomed
7.7.1 Ypsomed Company Information
7.7.2 Ypsomed Introduction and Business Overview
7.7.3 Ypsomed On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Ypsomed On-body Injectors Product Offerings
7.7.5 Ypsomed Recent Development
7.8 Enable Injections
7.8.1 Enable Injections Company Information
7.8.2 Enable Injections Introduction and Business Overview
7.8.3 Enable Injections On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Enable Injections On-body Injectors Product Offerings
7.8.5 Enable Injections Recent Development
7.9 Nemera
7.9.1 Nemera Company Information
7.9.2 Nemera Introduction and Business Overview
7.9.3 Nemera On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Nemera On-body Injectors Product Offerings
7.9.5 Nemera Recent Development
7.10 Stevanato Group
7.10.1 Stevanato Group Company Information
7.10.2 Stevanato Group Introduction and Business Overview
7.10.3 Stevanato Group On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Stevanato Group On-body Injectors Product Offerings
7.10.5 Stevanato Group Recent Development
7.11 Sonceboz
7.11.1 Sonceboz Company Information
7.11.2 Sonceboz Introduction and Business Overview
7.11.3 Sonceboz On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Sonceboz On-body Injectors Product Offerings
7.11.5 Sonceboz Recent Development
7.12 Lohmann Therapie-Systeme
7.12.1 Lohmann Therapie-Systeme Company Information
7.12.2 Lohmann Therapie-Systeme Introduction and Business Overview
7.12.3 Lohmann Therapie-Systeme On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Lohmann Therapie-Systeme On-body Injectors Product Offerings
7.12.5 Lohmann Therapie-Systeme Recent Development
7.13 Elcam Drug Delivery Devices (E3D)
7.13.1 Elcam Drug Delivery Devices (E3D) Company Information
7.13.2 Elcam Drug Delivery Devices (E3D) Introduction and Business Overview
7.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Elcam Drug Delivery Devices (E3D) On-body Injectors Product Offerings
7.13.5 Elcam Drug Delivery Devices (E3D) Recent Development
8 Industry Chain Analysis
8.1 On-body Injectors Industrial Chain
8.2 On-body Injectors Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 On-body Injectors Sales Model
8.5.2 Sales Channel
8.5.3 On-body Injectors Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 On-body Injectors Product Introduction
1.2 Global On-body Injectors Market Size Forecast
1.2.1 Global On-body Injectors Sales Value (2020-2031)
1.2.2 Global On-body Injectors Sales Volume (2020-2031)
1.2.3 Global On-body Injectors Sales Price (2020-2031)
1.3 On-body Injectors Market Trends & Drivers
1.3.1 On-body Injectors Industry Trends
1.3.2 On-body Injectors Market Drivers & Opportunity
1.3.3 On-body Injectors Market Challenges
1.3.4 On-body Injectors Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global On-body Injectors Players Revenue Ranking (2024)
2.2 Global On-body Injectors Revenue by Company (2020-2025)
2.3 Global On-body Injectors Players Sales Volume Ranking (2024)
2.4 Global On-body Injectors Sales Volume by Company Players (2020-2025)
2.5 Global On-body Injectors Average Price by Company (2020-2025)
2.6 Key Manufacturers On-body Injectors Manufacturing Base and Headquarters
2.7 Key Manufacturers On-body Injectors Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of On-body Injectors
2.9 On-body Injectors Market Competitive Analysis
2.9.1 On-body Injectors Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by On-body Injectors Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in On-body Injectors as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Electronic Injectors
3.1.2 Mechanical Injectors
3.2 Global On-body Injectors Sales Value by Type
3.2.1 Global On-body Injectors Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global On-body Injectors Sales Value, by Type (2020-2031)
3.2.3 Global On-body Injectors Sales Value, by Type (%) (2020-2031)
3.3 Global On-body Injectors Sales Volume by Type
3.3.1 Global On-body Injectors Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global On-body Injectors Sales Volume, by Type (2020-2031)
3.3.3 Global On-body Injectors Sales Volume, by Type (%) (2020-2031)
3.4 Global On-body Injectors Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Immuno-oncology
4.1.2 Cardiovascular Diseases
4.1.3 Neurological Diseases
4.1.4 Others
4.2 Global On-body Injectors Sales Value by Application
4.2.1 Global On-body Injectors Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global On-body Injectors Sales Value, by Application (2020-2031)
4.2.3 Global On-body Injectors Sales Value, by Application (%) (2020-2031)
4.3 Global On-body Injectors Sales Volume by Application
4.3.1 Global On-body Injectors Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global On-body Injectors Sales Volume, by Application (2020-2031)
4.3.3 Global On-body Injectors Sales Volume, by Application (%) (2020-2031)
4.4 Global On-body Injectors Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global On-body Injectors Sales Value by Region
5.1.1 Global On-body Injectors Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global On-body Injectors Sales Value by Region (2020-2025)
5.1.3 Global On-body Injectors Sales Value by Region (2026-2031)
5.1.4 Global On-body Injectors Sales Value by Region (%), (2020-2031)
5.2 Global On-body Injectors Sales Volume by Region
5.2.1 Global On-body Injectors Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global On-body Injectors Sales Volume by Region (2020-2025)
5.2.3 Global On-body Injectors Sales Volume by Region (2026-2031)
5.2.4 Global On-body Injectors Sales Volume by Region (%), (2020-2031)
5.3 Global On-body Injectors Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America On-body Injectors Sales Value, 2020-2031
5.4.2 North America On-body Injectors Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe On-body Injectors Sales Value, 2020-2031
5.5.2 Europe On-body Injectors Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific On-body Injectors Sales Value, 2020-2031
5.6.2 Asia Pacific On-body Injectors Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America On-body Injectors Sales Value, 2020-2031
5.7.2 South America On-body Injectors Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa On-body Injectors Sales Value, 2020-2031
5.8.2 Middle East & Africa On-body Injectors Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions On-body Injectors Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions On-body Injectors Sales Value
6.2.1 Key Countries/Regions On-body Injectors Sales Value, 2020-2031
6.2.2 Key Countries/Regions On-body Injectors Sales Volume, 2020-2031
6.3 United States
6.3.1 United States On-body Injectors Sales Value, 2020-2031
6.3.2 United States On-body Injectors Sales Value by Type (%), 2024 VS 2031
6.3.3 United States On-body Injectors Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe On-body Injectors Sales Value, 2020-2031
6.4.2 Europe On-body Injectors Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe On-body Injectors Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China On-body Injectors Sales Value, 2020-2031
6.5.2 China On-body Injectors Sales Value by Type (%), 2024 VS 2031
6.5.3 China On-body Injectors Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan On-body Injectors Sales Value, 2020-2031
6.6.2 Japan On-body Injectors Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan On-body Injectors Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea On-body Injectors Sales Value, 2020-2031
6.7.2 South Korea On-body Injectors Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea On-body Injectors Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia On-body Injectors Sales Value, 2020-2031
6.8.2 Southeast Asia On-body Injectors Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia On-body Injectors Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India On-body Injectors Sales Value, 2020-2031
6.9.2 India On-body Injectors Sales Value by Type (%), 2024 VS 2031
6.9.3 India On-body Injectors Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 West Pharmaceutical Services
7.1.1 West Pharmaceutical Services Company Information
7.1.2 West Pharmaceutical Services Introduction and Business Overview
7.1.3 West Pharmaceutical Services On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 West Pharmaceutical Services On-body Injectors Product Offerings
7.1.5 West Pharmaceutical Services Recent Development
7.2 Insulet
7.2.1 Insulet Company Information
7.2.2 Insulet Introduction and Business Overview
7.2.3 Insulet On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Insulet On-body Injectors Product Offerings
7.2.5 Insulet Recent Development
7.3 Gerresheimer
7.3.1 Gerresheimer Company Information
7.3.2 Gerresheimer Introduction and Business Overview
7.3.3 Gerresheimer On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Gerresheimer On-body Injectors Product Offerings
7.3.5 Gerresheimer Recent Development
7.4 United Therapeutics
7.4.1 United Therapeutics Company Information
7.4.2 United Therapeutics Introduction and Business Overview
7.4.3 United Therapeutics On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 United Therapeutics On-body Injectors Product Offerings
7.4.5 United Therapeutics Recent Development
7.5 CC Bio
7.5.1 CC Bio Company Information
7.5.2 CC Bio Introduction and Business Overview
7.5.3 CC Bio On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 CC Bio On-body Injectors Product Offerings
7.5.5 CC Bio Recent Development
7.6 BD
7.6.1 BD Company Information
7.6.2 BD Introduction and Business Overview
7.6.3 BD On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 BD On-body Injectors Product Offerings
7.6.5 BD Recent Development
7.7 Ypsomed
7.7.1 Ypsomed Company Information
7.7.2 Ypsomed Introduction and Business Overview
7.7.3 Ypsomed On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Ypsomed On-body Injectors Product Offerings
7.7.5 Ypsomed Recent Development
7.8 Enable Injections
7.8.1 Enable Injections Company Information
7.8.2 Enable Injections Introduction and Business Overview
7.8.3 Enable Injections On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Enable Injections On-body Injectors Product Offerings
7.8.5 Enable Injections Recent Development
7.9 Nemera
7.9.1 Nemera Company Information
7.9.2 Nemera Introduction and Business Overview
7.9.3 Nemera On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Nemera On-body Injectors Product Offerings
7.9.5 Nemera Recent Development
7.10 Stevanato Group
7.10.1 Stevanato Group Company Information
7.10.2 Stevanato Group Introduction and Business Overview
7.10.3 Stevanato Group On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Stevanato Group On-body Injectors Product Offerings
7.10.5 Stevanato Group Recent Development
7.11 Sonceboz
7.11.1 Sonceboz Company Information
7.11.2 Sonceboz Introduction and Business Overview
7.11.3 Sonceboz On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Sonceboz On-body Injectors Product Offerings
7.11.5 Sonceboz Recent Development
7.12 Lohmann Therapie-Systeme
7.12.1 Lohmann Therapie-Systeme Company Information
7.12.2 Lohmann Therapie-Systeme Introduction and Business Overview
7.12.3 Lohmann Therapie-Systeme On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Lohmann Therapie-Systeme On-body Injectors Product Offerings
7.12.5 Lohmann Therapie-Systeme Recent Development
7.13 Elcam Drug Delivery Devices (E3D)
7.13.1 Elcam Drug Delivery Devices (E3D) Company Information
7.13.2 Elcam Drug Delivery Devices (E3D) Introduction and Business Overview
7.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Elcam Drug Delivery Devices (E3D) On-body Injectors Product Offerings
7.13.5 Elcam Drug Delivery Devices (E3D) Recent Development
8 Industry Chain Analysis
8.1 On-body Injectors Industrial Chain
8.2 On-body Injectors Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 On-body Injectors Sales Model
8.5.2 Sales Channel
8.5.3 On-body Injectors Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. On-body Injectors Market Trends
Table 2. On-body Injectors Market Drivers & Opportunity
Table 3. On-body Injectors Market Challenges
Table 4. On-body Injectors Market Restraints
Table 5. Global On-body Injectors Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global On-body Injectors Revenue Market Share by Company (2020-2025)
Table 7. Global On-body Injectors Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global On-body Injectors Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market On-body Injectors Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers On-body Injectors Manufacturing Base and Headquarters
Table 11. Key Manufacturers On-body Injectors Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of On-body Injectors
Table 13. Global On-body Injectors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in On-body Injectors as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global On-body Injectors Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global On-body Injectors Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global On-body Injectors Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global On-body Injectors Sales Market Share in Value by Type (2020-2025)
Table 20. Global On-body Injectors Sales Market Share in Value by Type (2026-2031)
Table 21. Global On-body Injectors Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global On-body Injectors Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global On-body Injectors Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global On-body Injectors Sales Market Share in Volume by Type (2020-2025)
Table 25. Global On-body Injectors Sales Market Share in Volume by Type (2026-2031)
Table 26. Global On-body Injectors Price by Type (2020-2025) & (US$/Unit)
Table 27. Global On-body Injectors Price by Type (2026-2031) & (US$/Unit)
Table 28. Global On-body Injectors Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global On-body Injectors Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global On-body Injectors Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global On-body Injectors Sales Market Share in Value by Application (2020-2025)
Table 32. Global On-body Injectors Sales Market Share in Value by Application (2026-2031)
Table 33. Global On-body Injectors Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global On-body Injectors Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global On-body Injectors Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global On-body Injectors Sales Market Share in Volume by Application (2020-2025)
Table 37. Global On-body Injectors Sales Market Share in Volume by Application (2026-2031)
Table 38. Global On-body Injectors Price by Application (2020-2025) & (US$/Unit)
Table 39. Global On-body Injectors Price by Application (2026-2031) & (US$/Unit)
Table 40. Global On-body Injectors Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global On-body Injectors Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global On-body Injectors Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global On-body Injectors Sales Value by Region (2020-2025) & (%)
Table 44. Global On-body Injectors Sales Value by Region (2026-2031) & (%)
Table 45. Global On-body Injectors Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global On-body Injectors Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global On-body Injectors Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global On-body Injectors Sales Volume by Region (2020-2025) & (%)
Table 49. Global On-body Injectors Sales Volume by Region (2026-2031) & (%)
Table 50. Global On-body Injectors Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global On-body Injectors Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions On-body Injectors Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions On-body Injectors Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions On-body Injectors Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions On-body Injectors Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions On-body Injectors Sales Volume, (2026-2031) & (K Units)
Table 57. West Pharmaceutical Services Company Information
Table 58. West Pharmaceutical Services Introduction and Business Overview
Table 59. West Pharmaceutical Services On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. West Pharmaceutical Services On-body Injectors Product Offerings
Table 61. West Pharmaceutical Services Recent Development
Table 62. Insulet Company Information
Table 63. Insulet Introduction and Business Overview
Table 64. Insulet On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. Insulet On-body Injectors Product Offerings
Table 66. Insulet Recent Development
Table 67. Gerresheimer Company Information
Table 68. Gerresheimer Introduction and Business Overview
Table 69. Gerresheimer On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Gerresheimer On-body Injectors Product Offerings
Table 71. Gerresheimer Recent Development
Table 72. United Therapeutics Company Information
Table 73. United Therapeutics Introduction and Business Overview
Table 74. United Therapeutics On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. United Therapeutics On-body Injectors Product Offerings
Table 76. United Therapeutics Recent Development
Table 77. CC Bio Company Information
Table 78. CC Bio Introduction and Business Overview
Table 79. CC Bio On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. CC Bio On-body Injectors Product Offerings
Table 81. CC Bio Recent Development
Table 82. BD Company Information
Table 83. BD Introduction and Business Overview
Table 84. BD On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. BD On-body Injectors Product Offerings
Table 86. BD Recent Development
Table 87. Ypsomed Company Information
Table 88. Ypsomed Introduction and Business Overview
Table 89. Ypsomed On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Ypsomed On-body Injectors Product Offerings
Table 91. Ypsomed Recent Development
Table 92. Enable Injections Company Information
Table 93. Enable Injections Introduction and Business Overview
Table 94. Enable Injections On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Enable Injections On-body Injectors Product Offerings
Table 96. Enable Injections Recent Development
Table 97. Nemera Company Information
Table 98. Nemera Introduction and Business Overview
Table 99. Nemera On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Nemera On-body Injectors Product Offerings
Table 101. Nemera Recent Development
Table 102. Stevanato Group Company Information
Table 103. Stevanato Group Introduction and Business Overview
Table 104. Stevanato Group On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Stevanato Group On-body Injectors Product Offerings
Table 106. Stevanato Group Recent Development
Table 107. Sonceboz Company Information
Table 108. Sonceboz Introduction and Business Overview
Table 109. Sonceboz On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Sonceboz On-body Injectors Product Offerings
Table 111. Sonceboz Recent Development
Table 112. Lohmann Therapie-Systeme Company Information
Table 113. Lohmann Therapie-Systeme Introduction and Business Overview
Table 114. Lohmann Therapie-Systeme On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Lohmann Therapie-Systeme On-body Injectors Product Offerings
Table 116. Lohmann Therapie-Systeme Recent Development
Table 117. Elcam Drug Delivery Devices (E3D) Company Information
Table 118. Elcam Drug Delivery Devices (E3D) Introduction and Business Overview
Table 119. Elcam Drug Delivery Devices (E3D) On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Elcam Drug Delivery Devices (E3D) On-body Injectors Product Offerings
Table 121. Elcam Drug Delivery Devices (E3D) Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. On-body Injectors Downstream Customers
Table 125. On-body Injectors Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. On-body Injectors Product Picture
Figure 2. Global On-body Injectors Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global On-body Injectors Sales Value (2020-2031) & (US$ Million)
Figure 4. Global On-body Injectors Sales Volume (2020-2031) & (K Units)
Figure 5. Global On-body Injectors Sales Price (2020-2031) & (US$/Unit)
Figure 6. On-body Injectors Report Years Considered
Figure 7. Global On-body Injectors Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global On-body Injectors Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by On-body Injectors Revenue in 2024
Figure 10. On-body Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Electronic Injectors Picture
Figure 12. Mechanical Injectors Picture
Figure 13. Global On-body Injectors Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global On-body Injectors Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global On-body Injectors Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 16. Global On-body Injectors Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global On-body Injectors Price by Type (2020-2031) & (US$/Unit)
Figure 18. Product Picture of Immuno-oncology
Figure 19. Product Picture of Cardiovascular Diseases
Figure 20. Product Picture of Neurological Diseases
Figure 21. Product Picture of Others
Figure 22. Global On-body Injectors Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global On-body Injectors Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global On-body Injectors Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 25. Global On-body Injectors Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global On-body Injectors Price by Application (2020-2031) & (US$/Unit)
Figure 27. North America On-body Injectors Sales Value (2020-2031) & (US$ Million)
Figure 28. North America On-body Injectors Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe On-body Injectors Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific On-body Injectors Sales Value by Region (%), 2024 VS 2031
Figure 33. South America On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America On-body Injectors Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa On-body Injectors Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions On-body Injectors Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions On-body Injectors Sales Volume (%), (2020-2031)
Figure 39. United States On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States On-body Injectors Sales Value by Type (%), 2024 VS 2031
Figure 41. United States On-body Injectors Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe On-body Injectors Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe On-body Injectors Sales Value by Application (%), 2024 VS 2031
Figure 45. China On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 46. China On-body Injectors Sales Value by Type (%), 2024 VS 2031
Figure 47. China On-body Injectors Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan On-body Injectors Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan On-body Injectors Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea On-body Injectors Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea On-body Injectors Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia On-body Injectors Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia On-body Injectors Sales Value by Application (%), 2024 VS 2031
Figure 57. India On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 58. India On-body Injectors Sales Value by Type (%), 2024 VS 2031
Figure 59. India On-body Injectors Sales Value by Application (%), 2024 VS 2031
Figure 60. On-body Injectors Industrial Chain
Figure 61. On-body Injectors Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. On-body Injectors Market Trends
Table 2. On-body Injectors Market Drivers & Opportunity
Table 3. On-body Injectors Market Challenges
Table 4. On-body Injectors Market Restraints
Table 5. Global On-body Injectors Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global On-body Injectors Revenue Market Share by Company (2020-2025)
Table 7. Global On-body Injectors Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global On-body Injectors Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market On-body Injectors Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers On-body Injectors Manufacturing Base and Headquarters
Table 11. Key Manufacturers On-body Injectors Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of On-body Injectors
Table 13. Global On-body Injectors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in On-body Injectors as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global On-body Injectors Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global On-body Injectors Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global On-body Injectors Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global On-body Injectors Sales Market Share in Value by Type (2020-2025)
Table 20. Global On-body Injectors Sales Market Share in Value by Type (2026-2031)
Table 21. Global On-body Injectors Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global On-body Injectors Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global On-body Injectors Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global On-body Injectors Sales Market Share in Volume by Type (2020-2025)
Table 25. Global On-body Injectors Sales Market Share in Volume by Type (2026-2031)
Table 26. Global On-body Injectors Price by Type (2020-2025) & (US$/Unit)
Table 27. Global On-body Injectors Price by Type (2026-2031) & (US$/Unit)
Table 28. Global On-body Injectors Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global On-body Injectors Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global On-body Injectors Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global On-body Injectors Sales Market Share in Value by Application (2020-2025)
Table 32. Global On-body Injectors Sales Market Share in Value by Application (2026-2031)
Table 33. Global On-body Injectors Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global On-body Injectors Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global On-body Injectors Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global On-body Injectors Sales Market Share in Volume by Application (2020-2025)
Table 37. Global On-body Injectors Sales Market Share in Volume by Application (2026-2031)
Table 38. Global On-body Injectors Price by Application (2020-2025) & (US$/Unit)
Table 39. Global On-body Injectors Price by Application (2026-2031) & (US$/Unit)
Table 40. Global On-body Injectors Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global On-body Injectors Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global On-body Injectors Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global On-body Injectors Sales Value by Region (2020-2025) & (%)
Table 44. Global On-body Injectors Sales Value by Region (2026-2031) & (%)
Table 45. Global On-body Injectors Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global On-body Injectors Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global On-body Injectors Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global On-body Injectors Sales Volume by Region (2020-2025) & (%)
Table 49. Global On-body Injectors Sales Volume by Region (2026-2031) & (%)
Table 50. Global On-body Injectors Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global On-body Injectors Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions On-body Injectors Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions On-body Injectors Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions On-body Injectors Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions On-body Injectors Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions On-body Injectors Sales Volume, (2026-2031) & (K Units)
Table 57. West Pharmaceutical Services Company Information
Table 58. West Pharmaceutical Services Introduction and Business Overview
Table 59. West Pharmaceutical Services On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. West Pharmaceutical Services On-body Injectors Product Offerings
Table 61. West Pharmaceutical Services Recent Development
Table 62. Insulet Company Information
Table 63. Insulet Introduction and Business Overview
Table 64. Insulet On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. Insulet On-body Injectors Product Offerings
Table 66. Insulet Recent Development
Table 67. Gerresheimer Company Information
Table 68. Gerresheimer Introduction and Business Overview
Table 69. Gerresheimer On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Gerresheimer On-body Injectors Product Offerings
Table 71. Gerresheimer Recent Development
Table 72. United Therapeutics Company Information
Table 73. United Therapeutics Introduction and Business Overview
Table 74. United Therapeutics On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. United Therapeutics On-body Injectors Product Offerings
Table 76. United Therapeutics Recent Development
Table 77. CC Bio Company Information
Table 78. CC Bio Introduction and Business Overview
Table 79. CC Bio On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. CC Bio On-body Injectors Product Offerings
Table 81. CC Bio Recent Development
Table 82. BD Company Information
Table 83. BD Introduction and Business Overview
Table 84. BD On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. BD On-body Injectors Product Offerings
Table 86. BD Recent Development
Table 87. Ypsomed Company Information
Table 88. Ypsomed Introduction and Business Overview
Table 89. Ypsomed On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Ypsomed On-body Injectors Product Offerings
Table 91. Ypsomed Recent Development
Table 92. Enable Injections Company Information
Table 93. Enable Injections Introduction and Business Overview
Table 94. Enable Injections On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Enable Injections On-body Injectors Product Offerings
Table 96. Enable Injections Recent Development
Table 97. Nemera Company Information
Table 98. Nemera Introduction and Business Overview
Table 99. Nemera On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Nemera On-body Injectors Product Offerings
Table 101. Nemera Recent Development
Table 102. Stevanato Group Company Information
Table 103. Stevanato Group Introduction and Business Overview
Table 104. Stevanato Group On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Stevanato Group On-body Injectors Product Offerings
Table 106. Stevanato Group Recent Development
Table 107. Sonceboz Company Information
Table 108. Sonceboz Introduction and Business Overview
Table 109. Sonceboz On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Sonceboz On-body Injectors Product Offerings
Table 111. Sonceboz Recent Development
Table 112. Lohmann Therapie-Systeme Company Information
Table 113. Lohmann Therapie-Systeme Introduction and Business Overview
Table 114. Lohmann Therapie-Systeme On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Lohmann Therapie-Systeme On-body Injectors Product Offerings
Table 116. Lohmann Therapie-Systeme Recent Development
Table 117. Elcam Drug Delivery Devices (E3D) Company Information
Table 118. Elcam Drug Delivery Devices (E3D) Introduction and Business Overview
Table 119. Elcam Drug Delivery Devices (E3D) On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Elcam Drug Delivery Devices (E3D) On-body Injectors Product Offerings
Table 121. Elcam Drug Delivery Devices (E3D) Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. On-body Injectors Downstream Customers
Table 125. On-body Injectors Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. On-body Injectors Product Picture
Figure 2. Global On-body Injectors Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global On-body Injectors Sales Value (2020-2031) & (US$ Million)
Figure 4. Global On-body Injectors Sales Volume (2020-2031) & (K Units)
Figure 5. Global On-body Injectors Sales Price (2020-2031) & (US$/Unit)
Figure 6. On-body Injectors Report Years Considered
Figure 7. Global On-body Injectors Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global On-body Injectors Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by On-body Injectors Revenue in 2024
Figure 10. On-body Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Electronic Injectors Picture
Figure 12. Mechanical Injectors Picture
Figure 13. Global On-body Injectors Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global On-body Injectors Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global On-body Injectors Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 16. Global On-body Injectors Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global On-body Injectors Price by Type (2020-2031) & (US$/Unit)
Figure 18. Product Picture of Immuno-oncology
Figure 19. Product Picture of Cardiovascular Diseases
Figure 20. Product Picture of Neurological Diseases
Figure 21. Product Picture of Others
Figure 22. Global On-body Injectors Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global On-body Injectors Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global On-body Injectors Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 25. Global On-body Injectors Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global On-body Injectors Price by Application (2020-2031) & (US$/Unit)
Figure 27. North America On-body Injectors Sales Value (2020-2031) & (US$ Million)
Figure 28. North America On-body Injectors Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe On-body Injectors Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific On-body Injectors Sales Value by Region (%), 2024 VS 2031
Figure 33. South America On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America On-body Injectors Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa On-body Injectors Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions On-body Injectors Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions On-body Injectors Sales Volume (%), (2020-2031)
Figure 39. United States On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States On-body Injectors Sales Value by Type (%), 2024 VS 2031
Figure 41. United States On-body Injectors Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe On-body Injectors Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe On-body Injectors Sales Value by Application (%), 2024 VS 2031
Figure 45. China On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 46. China On-body Injectors Sales Value by Type (%), 2024 VS 2031
Figure 47. China On-body Injectors Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan On-body Injectors Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan On-body Injectors Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea On-body Injectors Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea On-body Injectors Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia On-body Injectors Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia On-body Injectors Sales Value by Application (%), 2024 VS 2031
Figure 57. India On-body Injectors Sales Value, (2020-2031) & (US$ Million)
Figure 58. India On-body Injectors Sales Value by Type (%), 2024 VS 2031
Figure 59. India On-body Injectors Sales Value by Application (%), 2024 VS 2031
Figure 60. On-body Injectors Industrial Chain
Figure 61. On-body Injectors Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Fatigue Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global Blast Impact Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global On-Line Analytical Processing (OLAP) Business Intelligence Consulting Services Market Research Report 2025
Jul 29, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232